Healthcare Management Alkermes Receives Fda Fast Track Designation For Nemvaleukin Alfa In Combination With Pembrolizumab… AIT News Desk Oct 26, 2021 - Second Fast Track Designation for Nemvaleukin - Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track…